IL6 and prostate cancer: In a study by Stanojkovic et al. [38], the evaluation of potential cytokine signatures in prostate cancer patients revealed significantly elevated circulating levels of IL-6 and IFN-γ in those receiving definitive radiotherapy compared to patients treated postoperatively.